drugset / Trial / NCT01633944
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if buprenorphine hydrochloride (HCl) buccal film is effective in treating opioid-naive subjects, with moderate to severe chronic low back pain (CLBP), who require continuous around-the-clock (ATC) pain relief for an extended period of time.
Timeline
- Start
- 2012-08
- Primary completion
- 2013-12
- Completion
- 2013-12
Outcome
Met primary endpoint
registry analysis (superiority or other test); DB Buprenorphine HCl Buccal Film vs DB Placebo Film; p = 0.0012; Median Difference (Net) -0.67 (95% CI -1.07 to -0.26); ANCOVA NCT01633944 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 75 ug | Other |
| Subject | Buprenorphine | Other / unclassified | 600 ug | Other |
Indications
No indication recorded.